Canakinumab Treat-To Target Strategies Increase Complete Response Rate in CAPS
Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-13-s1-p173
Full Text
Open PDFAbstract
Available in full text
Date
September 28, 2015
Authors
Publisher
Springer Science and Business Media LLC